Quidel is a diagnostic product manufacturer that produces and supplies rapid test kits and cellular-based virology assays for the healthcare sector.Read more
Quidel's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 196.8M. Over the last four quarters, Quidel's revenue has grown by 467.5%. Specifically, in Q1 2022's revenue was $1B; in Q4 2021, it was $636.9M; in Q3 2021, it was $509.7M; in Q2 2021, Quidel's revenue was $176.6M.